During the 1980s there was a resurgence of serious Streptococcus pyogenes infections with complications, including rheumatic fever, sepsis, severe soft-tissue invasion, and toxic-shock-like syndrome (TSLS). We have investigated the suggested association between expression of a scarlet fever toxin, SPE A, and systemic toxicity, and the possibility that a new highly virulent clone of S pyogenes has emerged and spread world wide. We studied serotype M1 strains, the serotype most commonly associated with serious complications. 19 isolates from patients with sepsis, with or without TSLS, and 48 from patients with uncomplicated pharyngitis or superficial skin infection were subjected to restriction-enzyme digestion and electrophoresis; 56 isolates (19 serious, 37 uncomplicated disease) were then examined by hybridisation to an speA gene probe. 17 (90%) of the 19 serious-disease isolates had a characteristic ("invasive", I) restriction-fragment profile and were positive for the speA gene. Significantly lower proportions of the isolates from patients with uncomplicated disease had the I profile (21/48 [44%]; p = 0.0035) and speA (20/37 [54%]; p less than 0.001). These findings suggest that the strains from patients with serious disease are a unique clone, which became the predominant cause of severe streptococcal infections in the United States and elsewhere in the late 1980s.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0140-6736(92)90339-5DOI Listing

Publication Analysis

Top Keywords

resurgence serious
8
serious streptococcus
8
streptococcus pyogenes
8
isolates patients
8
patients uncomplicated
8
uncomplicated disease
8
spea gene
8
serious
5
clonal basis
4
basis resurgence
4

Similar Publications

The article by Walker et al. (2025) titled "The American Psychological Association and Antisemitism: Toward Equity, Diversity, and Inclusion" regrettably suffers from serious shortcomings in regard to scholarship. These include flawed analyses, an overreliance on unreliable and biased sources, and the presentation of provocative and significant claims without any documentation at all.

View Article and Find Full Text PDF

Unreliable information and fear: Barriers to vaccination among IBD patients in China.

Hum Vaccin Immunother

December 2025

Center of Inflammatory Bowel Disease, Department of Gastroenterology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Vaccination plays a crucial role in safeguarding individuals with inflammatory bowel disease (IBD) from potential epidemics. In light of the resurgence of COVID-19 in China, unvaccinated IBD patients are vulnerable to infection and potentially serious complications. The aim of this study is to assess the vaccination uptake and willingness among IBD patients, as well as to explore the factors influencing their decision to decline vaccination.

View Article and Find Full Text PDF
Article Synopsis
  • M-pox is a rapidly spreading pathogen in developing countries, particularly in Cameroon, raising concerns about its health impact and the lack of data on its determinants.
  • A community-based study conducted in the Ayos Health District found a suspected M-pox case rate of 25%, with various factors like history of infections and contact with infected individuals or animals significantly linked to its prevalence.
  • The study highlights the need for enhanced surveillance and public health interventions in rural communities to better address the resurgence of M-pox.
View Article and Find Full Text PDF

Fine particulate matter (PM) pollution poses a serious threat to public health, and there has been a recent resurgence in PM pollution levels in China. Inter-provincial trade has further complicated the allocation of responsibility for PM emissions. An in-depth analysis of the Air Pollution Prevention and Control Action Plan (APPCAP), a highly effective environmental policy, offers new perspectives and avenues for reflection.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate a new low-cost pertussis booster vaccine with reduced doses of key components, comparing it to existing Tdap vaccines, due to a recent increase in pertussis cases.
  • Conducted in Thailand with 450 adolescents, the trial tested seroconversion rates among three vaccine groups to determine if the new vaccine was non-inferior compared to traditional options.
  • Results showed that the new vaccine (ap) had a 71% seroconversion rate for anti-FHA IgG, while Tdap had a higher rate of 94%, suggesting that the new vaccine still needs further investigation to improve immunogenicity.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!